SENS
SenseonicsFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
Current thesis
The best post-earnings bull argument is that Q1 showed real commercialization traction: revenue nearly doubled year over year, U.S. revenue more than doubled, gross margin expanded to 59%, and FY2026 revenue guidance was raised [#8-K-2026-05-07].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +0.2.
What can break
Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
Momentum
4
Value
37
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $7.20 · Bear $4.10
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $13.40
Why
Momentum4 · Δ7d -1.2
Value37 · Δ7d 0.0
Sentiment61 · Δ7d +0.2
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
4
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.2
Δ21d
-15.5
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.2
Sentiment
61
34% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+11.1
Why this grade
Composite grade F. Momentum 4.4 / Value 36.5 / Sentiment 61.4
Fundamentals (TTM)As of 2026-07-21
Fundamentals (TTM)
As of 2026-07-21
Market Cap
$262.58M
Beta
0.99
Shares Out
52.2M
P/E (TTM) · Derived
-3.0
P/S (TTM)
8.47
P/FCF (TTM) · Derived
-2.89
Rev YoY
+87.2%
EPS YoY
+77.8%
Gross Margin
+52.1%
Op Margin
-210.5%
Net Debt
-$52.97M
Current Ratio
3.51
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology